COM:SINGULARGENOMICS
Singular Genomics
- Stock
Last Close
21.90
21/11 21:00
Market Cap
19.05M
Beta: -
Volume Today
6.96K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 1.51M - | 10.62M 605.15% | 9.11M 14.18% | |||
average payables | 494K - | 1.39M 180.87% | 2.72M 96.29% | 1.55M 43.11% | ||
average receivables | 525K - | 981.50K 86.95% | 456.50K 53.49% | |||
book value per share | -0.50 - | -0.74 48.47% | 7.15 1,062.12% | 3.66 48.82% | ||
capex per share | -0.02 - | -0.02 22.83% | -0.10 420.06% | -0.08 18.17% | ||
capex to depreciation | -2.29 - | -2.16 5.52% | -4.29 98.79% | -1.00 76.75% | ||
capex to operating cash flow | 0.07 - | 0.06 20.95% | 0.09 69.57% | 0.07 26.50% | ||
capex to revenue | -7.87 - | |||||
cash per share | 0.94 - | 0.39 58.51% | 7.21 1,759.36% | 3.44 52.35% | ||
days of inventory on hand | 8.43K - | |||||
days payables outstanding | 1.43K - | |||||
days sales outstanding | 435.61 - | |||||
debt to assets | 0.05 - | 0.31 518.26% | 0.03 90.96% | 0.18 544.27% | ||
debt to equity | -0.10 - | -0.18 87.74% | 0.03 116.17% | 0.23 667.26% | ||
dividend yield | 0.01 - | |||||
earnings yield | -0.01 - | -0.02 65.37% | -0.18 1,032.60% | -0.62 239.30% | ||
enterprise value | 1.27B - | 1.78B 40.61% | 352.44M 80.22% | 127.59M 63.80% | ||
enterprise value over ebitda | -106.01 - | -67.53 36.29% | -5.82 91.38% | -1.42 75.68% | ||
ev to operating cash flow | -111.20 - | -71.65 35.56% | -6.82 90.49% | -1.46 78.51% | ||
ev to sales | 166.78 - | |||||
free cash flow per share | -0.25 - | -0.38 53.23% | -1.20 217.91% | -1.31 8.80% | ||
free cash flow yield | -0.01 - | -0.01 53.23% | -0.10 607.33% | -0.65 525.73% | ||
graham net net | -0.54 - | -0.79 47.02% | 6.85 961.78% | 2.62 61.68% | ||
graham number | 1.68 - | 2.63 56.69% | 18.39 599.84% | 10.11 45.05% | ||
income quality | 0.92 - | 0.89 3.77% | 0.52 41.19% | 0.96 83.09% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -751.18 - | -38.35 94.89% | -72.43 88.88% | -122.53 69.16% | ||
interest debt per share | 0.05 - | 0.15 197.92% | 0.23 56.84% | 0.84 266.47% | ||
inventory turnover | 0.04 - | |||||
invested capital | -0.10 - | -0.18 87.74% | 0.03 116.17% | 0.23 667.26% | ||
market cap | 1.27B - | 1.78B 40.44% | 543.59M 69.54% | 143.01M 73.69% | ||
net current asset value | -26.44M - | -54.49M 106.06% | 328.29M 702.51% | 200.78M 38.84% | ||
net debt to ebitda | 0.26 - | 0.09 66.49% | 3.16 3,533.40% | 0.17 94.58% | ||
net income per share | -0.25 - | -0.41 65.37% | -2.10 409.05% | -1.24 41.00% | ||
operating cash flow per share | -0.23 - | -0.36 55.37% | -1.10 206.70% | -1.22 11.34% | ||
payables turnover | 0.25 - | |||||
receivables turnover | 0.84 - | |||||
research and ddevelopement to revenue | 60.39 - | |||||
return on tangible assets | -0.26 - | -0.94 266.82% | -0.28 70.41% | -0.27 3.21% | ||
revenue per share | 0.01 - | |||||
roe | 0.50 - | 0.56 11.39% | -0.29 152.91% | -0.34 15.27% | ||
roic | 0.57 - | 0.67 16.95% | -0.18 126.46% | -0.25 39.21% | ||
sales general and administrative to revenue | ||||||
shareholders equity per share | -0.50 - | -0.74 48.47% | 7.15 1,062.12% | 3.66 48.82% | ||
stock based compensation to revenue | 17.87 - | |||||
tangible asset value | -24.73M - | -51.55M 108.51% | 336.17M 752.07% | 260.32M 22.56% | ||
tangible book value per share | -0.50 - | -0.74 48.47% | 7.15 1,062.12% | 3.66 48.82% | ||
working capital | 45.34M - | 23.88M 47.33% | 341.02M 1,327.98% | 254.31M 25.42% |
All numbers in (except ratios and percentages)